Open AccessTemporary Pretreatment With the Angiotensin II Type 1 Receptor Blocker, Valsartan, Prevents Ischemic Brain Damage Through an Increase in Capillary Density
Author(s) -
JianMei Li,
Masaki Mogi,
Jun Iwanami,
LiJuan Min,
Kana Tsukuda,
Akiko Sakata,
Teppei Fujita,
Masaru Iwai,
Masatsugu Horiuchi
Publication year - 2008
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.107.503458
Subject(s) - valsartan , medicine , middle cerebral artery , cerebral blood flow , endocrinology , nitric oxide , nitric oxide synthase , pharmacology , anesthesia , ischemia , blood pressure
We investigated the effect of temporary treatment with a nonhypotensive dose of valsartan on ischemic brain damage in C57BL/6 mice.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom